Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinghua Weikang Capsule for Maintenance Treatment of Reflux Esophagitis
NCT06056973Phase 4Unknown
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- Oct 2023
- Primary completion
- Oct 2025
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of Jinghuaweikang capsule in reflux esophagitis, sponsored by The First Affiliated Hospital of Dalian Medical University. Status: unknown.
02
Drugs
Jinghuaweikang capsule
03
Conditions
reflux esophagitis
Beyond the preview
Go deeper on NCT06056973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06056973.